Knowledge management in the area of drug discovery has become extremely critical due to the high cost involved in the R&D process. Despite spending more than any other industrial sector on R&D, the pharma industry is grossly inefficient and its pipeline output stands at a record low even though the automation of the research process has resulted in a huge increase in research data output.
Our range of drug discovery knowledge management services supports various demands to perform sophisticated healthcare and life sciences research for new drugs and repositioning of already approved drugs for the treatment of new disease. Data is curated from various sources covering public databases, proprietary information, pathways, clinical trials, patents and all available literature sources.